Chronic Refractory Cough Market Size To Hit US$ 13,821.3 Million By 2033
According to IMARC Group’s latest report, titled “ Chronic Refractory Cough Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033 ”, The 7 major chronic refractory cough markets reached a value of US$ 9,054.8 Million in 2022. Looking forward, IMARC Group expects the 7MM to reach US$ 13,821.3 Million by 2033, exhibiting a growth rate (CAGR) of 3.9% during 2023-2033.This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the market in any form. Industry Definition and Application: Chronic refractory cough (CRC) refers to an ailment in which an individual experiences a persistent cough that lasts for more than eight weeks, even after undergoing multiple treatments. The main symptoms of the disease involves a dry, irritated cough localized around the laryngeal area, dyspnea, dysphonia, dizziness, continuous chest pain, night sweats, and physical complica